The Next Cutting-Edge Technologies in Abdominal Solid Tumor Treatment

Dear Colleagues,

We are delighted to invite you to contribute to a Special Issue of Cancers titled “The Next Cutting-Edge Technologies in Abdominal Solid Tumor Treatment”.

This Special Issue will focus on multimodal approaches for the treatment of complex and advanced abdominal solid tumors using advanced technologies and surgical techniques such as cold atmospheric plasma, precision guided ai-robotic delivery of cold plasma, cytoreductive surgery, irreversible electroporation (IRE), hyperthermic intraperitoneal chemotherapy (HIPEC), pressurized intraperitoneal aerosol chemotherapy (PIPAC), pressurized intraperitoneal aerosol CAP (PIP-CAP) and transplant oncology.

Abdominal solid tumors—such as pancreatic, hepatic, ovarian, gastric, and colon cancers—pose major surgical challenges due to their complex microenvironment and high recurrence rates.

We welcome both original research articles and reviews. Research areas may include (but are not limited to) the following fields:

• The role of cold atmospheric plasma (CAP) in abdominal cancer treatment: mechanistic study of CAP induced apoptosis, immune modulation, and tumor redox biology;
• Study of CAP in relation to irreversible electroporation and with pressurized intraperitoneal aerosol;
• AI-Guided robotic CAP precision surgery;
• Cytoreductive surgery, HIPEC, and PIPAC;
• Multi-visceral surgical resection for complex abdominal tumors;
• Transplant surgical oncology;
• Immunological and molecular biomarker discovery in abdominal tumors.

We look forward to receiving your contributions.

Prof. Dr. Jerome Canady
Dr. Saravana R.K. Murthy
Prof. Dr. Aviram Nissan
Prof. Dr. Michael Keidar
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.